Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-108057
Filing Date
2025-11-07
Accepted
2025-11-07 06:06:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13862
2 EXHIBIT 1 tm2530429d1_ex-1.htm EX-1 5450
  Complete submission text file 0001104659-25-108057.txt   21206
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Subject) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-45573 | Film No.: 251460273
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 630 DUNDEE ROAD SUITE 230 NORTHBROOK IL 60062
Business Address 630 DUNDEE ROAD SUITE 230 NORTHBROOK IL 60062 8476561640
Trigran Investments, Inc. (Filed by) CIK: 0001336800 (see all company filings)

EIN.: 363825728 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SCHEDULE 13G/A